Literature DB >> 19787247

The characterization of blood flow changes in mouse tumor during Photofrin-based photodynamic therapy by using the color Doppler ultrasonography.

Karmen Dubreta1, Sinisa Ivankovic, Arijana Lovrencic-Huzjan, Marijana Bosnar-Puretic, Ranko Stojkovic, Mislav Jurin.   

Abstract

Changes in blood flow velocity through the tumors can induce damage of tumor microcirculation and thus may contribute to the final destruction of tumor masses after photodynamic therapy (PDT). The aim of this study was to evaluate the blood flow changes in a SCCVII mouse carcinoma during Photofrin-based photodynamic therapy by analyzing several quantitative spectral Doppler parameters [maximum systolic flow velocity (Vmax), end diastolic velocity (Vmin), resistance index (RI) and pulsatile index (PI)] by using the color Doppler ultrasonography. Blood flow velocities were recorded immediately prior to tumor illumination (0 h) and then 2 and 24 h after the illumination. Statistically significant increase in diastolic blood velocity (Vmin) with a corresponding decline in RI and PI was recorded in tumors of the Photofrin-injected mice prior to tumor illumination. However, 2 h after the illumination a pronounced decrease in both Vmin and Vmax was obtained. There were no changes of these parameters in controls at different times during determination. The observed changes of spectral Doppler parameters in tumors from the PDT group point to the transition of tumor blood vessels from the relaxation state recorded before tumor illumination into a state of increased contraction after the activation of Photofrin by light. Pronounced changes in tumor blood vessel tone might be an additional stress for such vessels leading to their ultimate destruction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787247     DOI: 10.3892/or_00000562

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).

Authors:  Tadanobu Nagaya; Yuko Nakamura; Kazuhide Sato; Toshiko Harada; Peter L Choyke; Hisataka Kobayashi
Journal:  J Control Release       Date:  2016-04-05       Impact factor: 9.776

Review 2.  Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?

Authors:  Yuko Nakamura; Ai Mochida; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2016-09-02       Impact factor: 4.774

Review 3.  Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?

Authors:  Hisataka Kobayashi; Rira Watanabe; Peter L Choyke
Journal:  Theranostics       Date:  2013-12-11       Impact factor: 11.556

Review 4.  Cancer drug delivery: considerations in the rational design of nanosized bioconjugates.

Authors:  Hisataka Kobayashi; Baris Turkbey; Rira Watanabe; Peter L Choyke
Journal:  Bioconjug Chem       Date:  2014-11-19       Impact factor: 4.774

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.